Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy
- PMID: 32521140
- DOI: 10.1056/NEJMc2002527
Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy
Comment on
-
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910. N Engl J Med. 2017. PMID: 28467869 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical